IQVIA HOLDINGS INC. Goodwill, Foreign Currency Translation Gain (Loss)
IQVIA HOLDINGS INC. (IQV) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$102.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-05-05
- IQVIA HOLDINGS INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$102.00M, a 146.58% decline year-over-year.
- IQVIA HOLDINGS INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was -$15.00M.
- IQVIA HOLDINGS INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was -$23.00M, a 107.90% decline year-over-year.
- IQVIA HOLDINGS INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-06-30 was $446.00M.
- IQVIA HOLDINGS INC. goodwill, foreign currency translation gain (loss) for fiscal 2025 was $627.00M.
- IQVIA HOLDINGS INC. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$389.00M, a 444.25% decline from fiscal 2023.
- IQVIA HOLDINGS INC. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $113.00M.
- IQVIA HOLDINGS INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$406.00M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | -$102.00M 10-Q · filed 2026-05-05 | -$117.00M derived: sum of 2 quarters · filed 2026-05-05 | -$140.00M derived: sum of 3 quarters · filed 2026-05-05 | $306.00M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-12-31 | -$15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$38.00M derived: sum of 2 quarters · filed 2026-02-17 | $408.00M derived: sum of 3 quarters · filed 2026-02-17 | $627.00M 10-K · filed 2026-02-17 | |
| 2025-09-30 | -$23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $423.00M derived: sum of 2 quarters · filed 2025-10-28 | $642.00M 10-Q · filed 2025-10-28 | $199.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2025-06-30 | $446.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $665.00M 10-Q · filed 2025-07-22 | $222.00M derived: sum of 3 quarters · filed 2026-02-17 | $513.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2025-03-31 | $219.00M 10-Q · filed 2025-05-06 | -$224.00M derived: sum of 2 quarters · filed 2026-02-17 | $67.00M derived: sum of 3 quarters · filed 2026-02-17 | -$16.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-12-31 | -$443.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$152.00M derived: sum of 2 quarters · filed 2026-02-17 | -$235.00M derived: sum of 3 quarters · filed 2026-02-17 | -$389.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $291.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $208.00M derived: sum of 2 quarters · filed 2024-10-31 | $54.00M 10-Q · filed 2024-10-31 | $312.00M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2024-06-30 | -$83.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22 | -$237.00M 10-Q · filed 2024-07-22 | $21.00M derived: sum of 3 quarters · filed 2025-02-13 | -$146.00M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2024-03-31 | -$154.00M 10-Q · filed 2024-05-02 | $104.00M derived: sum of 2 quarters · filed 2025-02-13 | -$63.00M derived: sum of 3 quarters · filed 2025-02-13 | -$117.00M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-12-31 | $258.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $91.00M derived: sum of 2 quarters · filed 2025-02-13 | $37.00M derived: sum of 3 quarters · filed 2025-02-13 | $113.00M 10-K · filed 2025-02-13 | |
| 2023-09-30 | -$167.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$221.00M derived: sum of 2 quarters · filed 2023-11-01 | -$145.00M 10-Q · filed 2023-11-01 | $312.00M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2023-06-30 | -$54.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $22.00M 10-Q · filed 2023-08-01 | $479.00M derived: sum of 3 quarters · filed 2024-02-15 | $122.00M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2023-03-31 | $76.00M 10-Q · filed 2023-04-28 | $533.00M derived: sum of 2 quarters · filed 2024-02-15 | $176.00M derived: sum of 3 quarters · filed 2024-02-15 | -$222.00M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-12-31 | $457.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $100.00M derived: sum of 2 quarters · filed 2024-02-15 | -$298.00M derived: sum of 3 quarters · filed 2024-02-15 | -$406.00M 10-K · filed 2024-02-15 | |
| 2022-09-30 | -$357.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$755.00M derived: sum of 2 quarters · filed 2022-10-27 | -$863.00M 10-Q · filed 2022-10-27 | -$974.00M derived: sum of 4 quarters · filed 2023-02-15 | |
| 2022-06-30 | -$398.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | -$506.00M 10-Q · filed 2022-07-22 | -$617.00M derived: sum of 3 quarters · filed 2023-02-15 | -$748.00M derived: sum of 4 quarters · filed 2023-02-15 | |
| 2022-03-31 | -$108.00M 10-Q · filed 2022-04-28 | -$219.00M derived: sum of 2 quarters · filed 2023-02-15 | -$350.00M derived: sum of 3 quarters · filed 2023-02-15 | -$267.00M derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-12-31 | -$111.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$242.00M derived: sum of 2 quarters · filed 2023-02-15 | -$159.00M derived: sum of 3 quarters · filed 2023-02-15 | -$413.00M 10-K · filed 2023-02-15 | |
| 2021-09-30 | -$131.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | -$48.00M derived: sum of 2 quarters · filed 2021-10-22 | -$302.00M 10-Q · filed 2021-10-22 | -$42.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2021-06-30 | $83.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$171.00M 10-Q · filed 2021-07-28 | $89.00M derived: sum of 3 quarters · filed 2022-02-16 | $305.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2021-03-31 | -$254.00M 10-Q · filed 2021-04-23 | $6.00M derived: sum of 2 quarters · filed 2022-02-16 | $222.00M derived: sum of 3 quarters · filed 2022-02-16 | $308.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-12-31 | $260.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $476.00M derived: sum of 2 quarters · filed 2022-02-16 | $562.00M derived: sum of 3 quarters · filed 2022-02-16 | $380.00M 10-K · filed 2022-02-16 | |
| 2020-09-30 | $216.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | $302.00M derived: sum of 2 quarters · filed 2020-10-22 | $120.00M 10-Q · filed 2020-10-22 | $257.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2020-06-30 | $86.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | -$96.00M 10-Q · filed 2020-07-23 | $41.00M derived: sum of 3 quarters · filed 2021-02-12 | -$165.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2020-03-31 | -$182.00M 10-Q · filed 2020-04-30 | -$45.00M derived: sum of 2 quarters · filed 2021-02-12 | -$251.00M derived: sum of 3 quarters · filed 2021-02-12 | -$191.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-12-31 | $137.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$69.00M derived: sum of 2 quarters · filed 2021-02-12 | -$9.00M derived: sum of 3 quarters · filed 2021-02-12 | -$77.00M 10-K · filed 2021-02-12 | $77.00M 10-K · filed 2020-02-18 |
| 2019-09-30 | -$206.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$146.00M derived: sum of 2 quarters · filed 2019-11-01 | -$214.00M 10-Q · filed 2019-11-01 | $252.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2019-06-30 | $60.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$8.00M 10-Q · filed 2019-07-24 | $458.00M derived: sum of 3 quarters · filed 2020-02-18 | $384.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2019-03-31 | -$68.00M 10-Q · filed 2019-05-02 | $398.00M derived: sum of 2 quarters · filed 2020-02-18 | $324.00M derived: sum of 3 quarters · filed 2020-02-18 | $0.00 derived: sum of 4 quarters · filed 2020-02-18 | |
| 2018-12-31 | $466.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $392.00M derived: sum of 2 quarters · filed 2020-02-18 | $68.00M derived: sum of 3 quarters · filed 2020-02-18 | $252.00M 10-K · filed 2020-02-18 | |
| 2018-09-30 | -$74.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | -$398.00M derived: sum of 2 quarters · filed 2018-10-25 | -$214.00M 10-Q · filed 2018-10-25 | -$1.32B derived: sum of 4 quarters · filed 2019-02-19 | |
| 2018-06-30 | -$324.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$140.00M 10-Q · filed 2018-07-27 | -$1.24B derived: sum of 3 quarters · filed 2019-02-19 | -$1.08B derived: sum of 4 quarters · filed 2019-02-19 | |
| 2018-03-31 | $184.00M 10-Q · filed 2018-05-04 | -$919.00M derived: sum of 2 quarters · filed 2019-02-19 | -$755.00M derived: sum of 3 quarters · filed 2019-02-19 | -$494.00M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-12-31 | -$1.10B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$939.00M derived: sum of 2 quarters · filed 2019-02-19 | -$678.00M derived: sum of 3 quarters · filed 2019-02-19 | -$582.00M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $164.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $425.00M derived: sum of 2 quarters · filed 2017-10-27 | $521.00M 10-Q · filed 2017-10-27 | $872.15M derived: sum of 4 quarters · filed 2017-10-27 | |
| 2017-06-30 | $261.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $357.00M 10-Q · filed 2017-08-04 | $708.15M derived: sum of 3 quarters · filed 2017-08-04 | $706.10M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2017-03-31 | $96.00M 10-Q · filed 2017-05-08 | $447.15M derived: sum of 2 quarters · filed 2017-05-08 | $445.10M derived: sum of 3 quarters · filed 2017-05-08 | ||
| 2016-12-31 | $351.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $349.10M derived: sum of 2 quarters · filed 2017-02-16 | $346.00M 10-K · filed 2017-02-16 | ||
| 2016-09-30 | -$2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$5.15M 10-Q · filed 2016-11-03 | |||
| 2016-06-30 | -$3.10M 10-Q · filed 2016-07-27 | ||||
| 2015-12-31 | $346.00M 10-K · filed 2018-02-16 | $6.00M 10-K · filed 2017-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |